Shareholders holding 5% or more of voting rights at Extraordinary General Meeting on 28 April 2025

Date: 28 April 2025

Subject: Shareholders holding 5% or more of voting rights at Extraordinary General Meeting on 28 April 2025

Legal basis: Art. 70.3 of the Public Offering Act – Shareholders holding 5% or more of total voting rights at General Meeting

The Management Board of Diagnostyka S.A. of Kraków (the “Company”) announces that the following shareholders held 5% or more of total voting rights at the Company’s Extraordinary General Meeting held on 28 April 2025:

• Jakub Swadźba, holding voting rights attached to 3,186,189 shares, which carry a total of 6,372,378 votes, representing approximately 15.45% of total voting rights at the Extraordinary General Meeting and 12.82% of total voting rights in the Company;
• ACER CAPITAL PARTNERS SCSP, holding voting rights attached to 6,372,278 shares, which carry a total of 12,744,556 votes, representing approximately 30.90% of total voting rights at the Extraordinary General Meeting and 25.65% of total voting rights in the Company;
• ACACIA CAPITAL PARTNERS SCSP, holding voting rights attached to 6,372,278 shares, which carry a total of 12,744,556 votes, representing approximately 30.90% of total voting rights at the Extraordinary General Meeting and 25.65% of total voting rights in the Company;

Signatures of authorised representatives:
Jakub Swadźba – President of the Management Board
Paweł Chytła – Vice President of the Management Board